EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SHP2‐Triggered Endothelial Cell Activation Fuels Estradiol‐Independent Endometrial Sterile Inflammation

Jie Pan, Jiao Qu, Wen Fang, Lixin Zhao, Wei Zheng, Linhui Zhai, Minjia Tan, Qiang Xu, Qianming Du, Wen Lv, Yang Sun iD

Advanced Science · 2024

DOI: 10.1002/advs.202403038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Jie Pan und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology and Nanjing Drum Tower Hospital the Affiliated Hospital of Nanjing University Medical School, Sc…. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 11, Estradiol, Inflammation, Endothelial Cells. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Plan, National Natural Science Foundation of China, School of Life Science (NJU)-Sipimo Joint Funds, Mountain-Climbing Talents Project of Nanjing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sterile inflammation occurs in various chronic diseases due to many nonmicrobe factors. Examples include endometrial hyperplasia (EH), endometriosis, endometrial cancer, and breast cancer, which are all sterile inflammation diseases induced by estrogen imbalances. However, how estrogen‐induced sterile inflammation regulates EH remains unclear. Here, a single‐cell RNA‐Seq is used to show that SHP2 upregulation in endometrial endothelial cells promotes their inflammatory activation and subsequent transendothelial macrophage migration. Independent of the initial estrogen stimulation, IL1β and TNFα from macrophages then create a feedforward loop that enhances endothelial cell activation and IGF1 secretion. This endothelial cell–macrophage interaction sustains sterile endometrial inflammation and facilitates epithelial cell proliferation, even after estradiol withdrawal. The bulk RNA‐Seq results and phosphoproteomic analysis show that endothelial SHP2 mechanistically enhances RIPK1 activity by dephosphorylating RIPK1 Tyr380 . This event activates downstream activator protein 1 (AP‐1) and instigates the inflammation response. Furthermore, targeting SHP2 using SHP099 (an allosteric inhibitor) or endothelial‐specific SHP2 deletion alleviates endothelial cell activation, macrophage infiltration, and EH progression in mice. Collectively, the findings demonstrate that SHP2 mediates the transition of endothelial activation from estradiol‐driven acute inflammation to macrophage‐amplified chronic inflammation. Targeting sterile inflammation mediated by endothelial cell activation is a promising strategy for nonhormonal intervention in estrogen‐related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Tyrosine Phosphatase, Non-Receptor Type 11EstradiolInflammationEndothelial CellsEndometriumFemaleAnimalsMiceHumansDisease Models, AnimalMacrophagesMice, Inbred C57BLEndometrial Hyperplasia

Stichwörter der Autor:innen

SHP2‐RIPK1‐AP‐1 axiscell–cell interactionendometrial hyperplasiaendothelial cell activationsterile inflammation

Substanzen

Protein Tyrosine Phosphatase, Non-Receptor Type 11EstradiolPtpn11 protein, mouse

Autor:innen und Institutionen

  • State Key Laboratory of Pharmaceutical Biotechnology and Nanjing Drum Tower Hospital the Affiliated Hospital of Nanjing University Medical School, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing…
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, Jiangsu, 221004, China.
  • Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
  • School of Basic Medicine & Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
  • Department of Gynecology, Tongde Hospital of Zhejiang Province, 234 Gucui Road, Hangzhou, Zhejiang, 310012, China.

ORCID-Profile: Yang Sun

Förderung

  • National Key Research and Development Plan
  • National Natural Science Foundation of China
  • School of Life Science (NJU)-Sipimo Joint Funds, Mountain-Climbing Talents Project of Nanjing
  • Zhejiang Basic Public Welfare Research Project
  • Key Project of Zhejiang Traditional Chinese Medicine Science and Technology Plan
  • Zhejiang Medical and Health Science and Technology Project

Zitieren

APA

Pan, J., Qu, J., Fang, W., Zhao, L., Zheng, W., Zhai, L., Tan, M., Xu, Q., Du, Q., Lv, W., & Sun, Y. (2024). SHP2‐Triggered Endothelial Cell Activation Fuels Estradiol‐Independent Endometrial Sterile Inflammation. Advanced Science. https://doi.org/10.1002/advs.202403038

Vancouver

Pan J, Qu J, Fang W, Zhao L, Zheng W, Zhai L, et al. SHP2‐Triggered Endothelial Cell Activation Fuels Estradiol‐Independent Endometrial Sterile Inflammation. Advanced Science. 2024. doi:10.1002/advs.202403038

BibTeX
@article{Pan2024,
  author = {Pan, Jie and Qu, Jiao and Fang, Wen and Zhao, Lixin and Zheng, Wei and Zhai, Linhui and Tan, Minjia and Xu, Qiang and Du, Qianming and Lv, Wen and Sun, Yang},
  title = {SHP2‐Triggered Endothelial Cell Activation Fuels Estradiol‐Independent Endometrial Sterile Inflammation},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202403038}
}
Kostenlos starten →